Ligand validation:9IKG

LFA: EICOSANE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9IKG_LFA_P_313	33%	92%	0.187	0.912	0.27	0.24	-	-	0	0	75%	0.6
9IKG_LFA_P_309	33%	95%	0.219	0.915	0.23	0.18	-	-	1	0	90%	0.4
9IKG_LFA_C_309	30%	94%	0.211	0.893	0.29	0.14	-	-	2	0	90%	0.4
9IKG_LFA_N_607	28%	90%	0.213	0.918	0.37	0.25	-	-	6	0	70%	0.6
9IKG_LFA_A_607	18%	92%	0.243	0.885	0.31	0.21	-	-	5	0	70%	0.6
9IKG_LFA_B_307	18%	91%	0.28	0.895	0.31	0.25	-	-	0	0	85%	0.6
9IKG_LFA_C_307	15%	98%	0.266	0.911	0.2	0.09	-	-	4	0	55%	0.4
9IKG_LFA_O_302	15%	97%	0.284	0.871	0.19	0.12	-	-	1	0	85%	0.6
9IKG_LFA_T_101	12%	80%	0.27	0.856	0.51	0.33	-	-	6	0	70%	0.6
9IKG_LFA_C_314	12%	87%	0.262	0.836	0.23	0.45	-	-	1	0	75%	0.6
9IKG_LFA_P_314	12%	91%	0.282	0.871	0.32	0.27	-	-	0	0	65%	0.6
9IKG_LFA_C_315	11%	95%	0.284	0.867	0.21	0.2	-	-	1	0	65%	0.6
9IKG_LFA_T_103	9%	95%	0.289	0.868	0.25	0.15	-	-	0	0	55%	0.6
9IKG_LFA_C_310	9%	98%	0.334	0.876	0.15	0.1	-	-	0	0	75%	0.4
9IKG_LFA_P_311	9%	95%	0.321	0.871	0.25	0.15	-	-	0	0	70%	0.5
9IKG_LFA_P_312	8%	95%	0.287	0.84	0.17	0.24	-	-	1	0	55%	0.5
9IKG_LFA_C_312	7%	95%	0.337	0.851	0.23	0.18	-	-	0	0	70%	0.5
9IKG_LFA_C_311	7%	96%	0.343	0.874	0.19	0.18	-	-	0	0	55%	0.5
9IKG_LFA_N_608	6%	79%	0.316	0.806	0.54	0.33	-	-	5	0	70%	0.6
9IKG_LFA_P_307	5%	91%	0.345	0.836	0.3	0.26	-	-	2	0	55%	0.4
9IKG_LFA_O_303	5%	92%	0.351	0.834	0.35	0.17	-	-	0	0	55%	0.6
9IKG_LFA_P_308	5%	96%	0.348	0.875	0.21	0.14	-	-	0	0	30%	0.4
9IKG_LFA_C_326	5%	98%	0.414	0.859	0.18	0.12	-	-	0	0	75%	0.4
9IKG_LFA_C_313	4%	94%	0.333	0.804	0.22	0.23	-	-	1	0	55%	0.5
9IKG_LFA_P_310	3%	99%	0.405	0.808	0.14	0.07	-	-	0	0	55%	0.5
9IKG_LFA_C_308	2%	98%	0.417	0.843	0.2	0.1	-	-	0	0	30%	0.4
9IKI_LFA_N_608	41%	91%	0.169	0.937	0.29	0.29	-	-	5	0	70%	0.6
9KUM_LFA_P_313	32%	90%	0.187	0.908	0.38	0.22	-	-	1	0	75%	0.6
8H8R_LFA_C_309	31%	95%	0.194	0.878	0.22	0.19	-	-	10	0	90%	0.4
9KUK_LFA_P_314	30%	86%	0.19	0.896	0.46	0.26	-	-	3	0	75%	0.6
9IKH_LFA_N_609	29%	86%	0.203	0.915	0.33	0.38	-	-	6	0	70%	0.6
9I6I_LFA_D_313	67%	69%	0.117	0.953	0.3	0.86	-	-	0	0	85%	1
6SU4_LFA_X_616	66%	100%	0.113	0.917	0.09	0.1	-	-	0	0	100%	1
6SU3_LFA_X_301	65%	96%	0.071	0.945	0.18	0.18	-	-	0	0	60%	1
9I6H_LFA_C_309	61%	69%	0.136	0.926	0.29	0.88	-	-	0	0	100%	1
7AKY_LFA_A_403	58%	99%	0.088	0.911	0.08	0.14	-	-	7	0	75%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.